viagra liverpool uk where to buy viagra in sydney viagra in australia prescription
ventolin hfa doses flagyl order online ventolin buy online usa
koop cialis viagra rezeptfrei auf rechnung viagra ordonnance
cheapest place to buy fluconazole 
how do you get amoxicillin without a prescription 
asda pharmacy ventolin inhaler 
vente libre piligy pharmacie france nolvadex 10mg pantoprazole pharmacie
5 mg paxil works cheap generic clomid online clomiphene citrate 50 mg pills
buy microsoft office 2010 professional buying photoshop elements 12 mac download adobe creative suite 6 mac
windows 7 price canada quicken 2007 home business purchase windows 7 serial key

Australian research grant targets oral cancer

Sun, Dec 23, 2012

Oral Cancer News

Source: www.drbicuspid.com
Author: staff

Hans Zoellner, BDS, PhD, an associate professor and head of oral pathology at the University of Sydney, has been awarded the 2012 Australian Dental Industry Association (ADIA) Research Grant.

The grant supports research into the relationship of malignant cancer cells and those of healthy gingival structural tissue (fibroblasts). The findings of this research originated from earlier work studying aspects of oral cancer and have shed light on other forms of cancer.

The grant, funded by ADIA, is awarded each year to the primary applicant for the highest-ranked research project of those considered by the Australian Dental Research Foundation (ADRF).

Dr. Zoellner’s project, “Characterization of protein and mRNA exchange between malignant cells and fibroblasts,” was considered by the ADRF Grant Committee to be ground-breaking research into how cancer cells behave and potentially evade treatment.

“We have recently observed that cancer cells exchange cellular material with fibroblasts, and the resulting cancer cell diversity may help cancer cells evade chemotherapy. Separately, from an immune standpoint, it seems likely that the cancer cells receive enough components of fibroblasts so that they are less recognized as foreign, while the fibroblasts now bearing cancer cell components would act as immune decoys,” Dr. Zoellner explained in a press release. “In understanding this process, we hope to eventually inhibit the mechanisms through which it occurs and therefore increase the effectiveness of treatments.”

The Australian Dental Research Foundation is jointly supported by ADIA and the Australian Dental Association for the purpose of sponsoring dental research toward improving the dental health of the people of Australia.

Print Friendly
Be Sociable, Share!
, , ,

Leave a Reply

You must be logged in to post a comment.